Table 1. Cutaneous tuberculosis in Sri Lanka: Demographic Characteristics and therapeutic response of 12 patients with Lupus Vulgaris

Patient number

Age

Sex

Site

Clinical presentation

Size (cm)

Duration

Contact/ past History of TB

ESR mmh-1

Mantoux test (diameter) (mm)

TB culture

Treatment

Treatment response

Other comments

1

(figure 2)

40

F

nose

Erythematous plaque

3.0x 3.5 cm

10 months

no

9

 <10mm

ND

CAT I

disappeared in 2 months

 

2

59

F

R/cheek

Erythematous plaque

3x2.5 cm

2 years

no

13

13mm

ND

CAT I

Partial clinical response

 

3

9

M

nose

Erythematous plaque

0.4x0.5 cm

4 months

no

5

<10mm

negative

CAT I

disappeared in 3 months

 

4

38

F

L/calf

Erythematous plaque

0.4x0.5 cm

2 years

no

13

18mm

ND

CAT I

disappeared in 2 months

 

5

60

F

chin

Erythematous plaque

3.5x4 cm

4 months

no

10

ND

ND

CAT I

Lesion disappeared

Treated for borderline lepromatous leprosy 6 months ago

6

57

F

R/cheek

Erythematous plaque

1x3 cm

2 years

no

30

ND

ND

CAT I

disappeared in 2 months

Lesion reduced after skin biopsy

 

7

34

F

chin

Erythematous plaque

3x3.5 cm

3 years

no

98

<10mm

ND

CAT I

disappeared in 2 months

 

8

27

F

R/cheek

Erythematous plaque

1.5x2 cm

2 years

no

18

<10mm

ND

CAT I

disappeared in 2 months

 

9

(figure 3)

61

M

Trunk

Atrophic centre with active edge

30 x40 cm

20 years

No

35

<10mm

negative

CAT I

 

Healed with a scar

 

10

(figure 4)

48

F

R/Ulnar border

Atrophic centre with active edge

4x5 cm

4 months

no

115

15mm

negative

CAT I

Healed with a scar

On oral prednisolone for MCTD

11

26

M

Back of trunk, R/flank

Atrophic centre with active edge

2x2.5 cm

4 months

no

10

<10mm

negative

CAT I

Partial clinical response

Completely healed after cryotherapy

12

(figure11)

52

M

Back of trunk, L/flank

Atrophic centre with active edge

10x4 cm

5 years

no

20

<10mm

negative

CAT I

Partial clinical response

Completely healed after cryotherapy

 

F- female, M – male, MCTD - mixed connective tissue disease, ND- not done, CAT I-first line anti-TB drugs